These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 9544684)

  • 1. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
    Jager PL; Hazenberg BP; Franssen EJ; Limburg PC; van Rijswijk MH; Piers DA
    J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance and prognostic value of extravascular retention of 123I-labeled serum amyloid P component in systemic amyloidosis.
    Hazenberg BP; van Rijswijk MH; Lub-de Hooge MN; Vellenga E; Haagsma EB; Posthumus MD; Jager PL
    J Nucl Med; 2007 Jun; 48(6):865-72. PubMed ID: 17504868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis.
    Hazenberg BP; van Rijswijk MH; Piers DA; Lub-de Hooge MN; Vellenga E; Haagsma EB; Hawkins PN; Jager PL
    Am J Med; 2006 Apr; 119(4):355.e15-24. PubMed ID: 16564782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis.
    Hachulla E; Maulin L; Deveaux M; Facon T; Blétry O; Vanhille P; Wechsler B; Godeau P; Levesque H; Hatron PY; Huglo D; Devulder B; Marchandise X
    Am J Med; 1996 Jul; 101(1):77-87. PubMed ID: 8686719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component.
    Hawkins PN; Lavender JP; Pepys MB
    N Engl J Med; 1990 Aug; 323(8):508-13. PubMed ID: 2377176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis.
    Hawkins PN; Aprile C; Capri G; Viganò L; Munzone E; Gianni L; Pepys MB; Merlini G
    Eur J Nucl Med; 1998 Jul; 25(7):701-8. PubMed ID: 9662591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic studies of radioiodinated serum amyloid P component in normal subjects and patients with systemic amyloidosis.
    Hawkins PN; Wootton R; Pepys MB
    J Clin Invest; 1990 Dec; 86(6):1862-9. PubMed ID: 2254450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
    Gillmore JD; Lovat LB; Persey MR; Pepys MB; Hawkins PN
    Lancet; 2001 Jul; 358(9275):24-9. PubMed ID: 11454373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific localization and imaging of amyloid deposits in vivo using 123I-labeled serum amyloid P component.
    Hawkins PN; Myers MJ; Epenetos AA; Caspi D; Pepys MB
    J Exp Med; 1988 Mar; 167(3):903-13. PubMed ID: 3351437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis.
    Saïle R; Deveaux M; Hachulla E; Descamps J; Duquesnoy B; Marchandise X
    Eur J Nucl Med; 1993 Feb; 20(2):130-7. PubMed ID: 8440269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Localized amyloidosis': 123I-labelled SAP component scintigraphy and labial salivary gland biopsy.
    Maulin L; Hachulla E; Deveaux M; Janin A; Wechsler B; Godeau P; Rousset H; Barrier JH; Hatron PY; Devulder B; Huglo D; Marchandise X
    QJM; 1997 Jan; 90(1):45-50. PubMed ID: 9093588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Scintigraphy of iodine 123 labelled serum amyloid P component in beta 2-microglobulin amyloidosis of hemodialysis].
    Flipo RM; Deveaux M; Duneton O; Foissac-Gegoux P; Dumont A; Duquesnoy B; Marchandise X
    Nephrologie; 1995; 16(6):419-25. PubMed ID: 8524449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of complete screening for amyloid fibril type and systemic disease in patients with amyloidosis in the respiratory tract.
    Shah PL; Gillmore JD; Copley SJ; Collins JV; Wells AU; du Bois RM; Hawkins PN; Nicholson AG
    Sarcoidosis Vasc Diffuse Lung Dis; 2002 Jun; 19(2):134-42. PubMed ID: 12102609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis.
    Hawkins PN; Richardson S; Vigushin DM; David J; Kelsey CR; Gray RE; Hall MA; Woo P; Lavender JP; Pepys MB
    Arthritis Rheum; 1993 Jun; 36(6):842-51. PubMed ID: 8507227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and monitoring of amyloidosis.
    Hawkins PN
    Baillieres Clin Rheumatol; 1994 Aug; 8(3):635-59. PubMed ID: 7954867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients.
    Lovat LB; Persey MR; Madhoo S; Pepys MB; Hawkins PN
    Gut; 1998 May; 42(5):727-34. PubMed ID: 9659172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma kinetics of 125I-labelled amyloid P component in beta 2M amyloidosis: a possible approach to quantitate disease activity.
    Zingraff J; Caillat-Vigneron N; Ureña P; Gagné ER; Bererhi L; Moretti JL; Bardin T; Drüeke TB
    Nephrol Dial Transplant; 1995; 10(2):223-9. PubMed ID: 7753457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival in systemic amyloid A amyloidosis complicating Crohn's disease.
    Lovat LB; Madhoo S; Pepys MB; Hawkins PN
    Gastroenterology; 1997 Apr; 112(4):1362-5. PubMed ID: 9098022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression.
    Hawkins PN; Richardson S; MacSweeney JE; King AD; Vigushin DM; Lavender JP; Pepys MB
    Q J Med; 1993 Jun; 86(6):365-74. PubMed ID: 8171184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of primary amyloidosis using scintigraphy with the serum amyloid P component: from diagnosis to prognosis].
    Maulin L; Hachulla E; Facon T; Deveaux M; Blétry O; Vanhille P; Wechsler B; Godeau P; Levesque H; Marchandise W
    Rev Med Interne; 1993; 14(10):962. PubMed ID: 8009058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.